Skip to content
The Nexus
DossierENTITY

Dr. Reisa Sperling

Coverage of Dr. Reisa Sperling in the Nexus archive.

Earliest in view: Jul 15 · 04:05 UTCMost recent: Jul 15 · 04:05 UTC
Co-mentioned in this coverage
Mass General Brigham Neuroscience Instituteorganization2p-tau217 testtopic2Alzheimer's diseasetopic2JAMAorganization2Alzheimer’s Association International Conferenceorganization2
Recent coverage
  • HEALTHJul 15 · 04:05 UTCWDIV CLICKONDETROIT
    Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease

    A blood test measuring p-tau217 levels can predict the risk of Alzheimer's disease in symptom-free older adults, with high levels correlating to a 38% five-year and 78% ten-year risk of cognitive decline. The test is currently used in clinical settings to aid diagnosis but is not yet recommended for healthy individuals, as no interventions exist for early-stage prevention.

  • HEALTHJul 15 · 04:05 UTCWPLG LOCAL 10 MIAMI
    Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease

    A blood test measuring p-tau217 can predict the risk of Alzheimer's disease in healthy older adults, with high levels correlating to a 78% risk of cognitive impairment within 10 years. Researchers caution the test is not yet ready for general use but emphasize its potential to aid drug development and clinical trials.

Dr. Reisa Sperling · Dossier · The Nexus